About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Herpesvirus 2, Human ‐ A species of SIMPLEXVIRUS associated with genital infections…
- Transportation Noises ‐ Noise associated with transportation, particularly aircraft and…
- Switch Sequences, Ig ‐ A site on a segment of a B-cell immunoglobulin heavy-chain gene…
- Coal ‐ A natural fuel formed by partial decomposition of vegetable matter…
- Fatty Acid Desaturases ‐ Enzymes that catalyze the conversion of saturated fatty acid…
- Shared Services, Hospital ‐ Cooperation among hospitals for the purpose of sharing various…
- Family Planning, Natural ‐ Programs or services designed to assist the family in controlling…
- Ligases, Succinate-CoA ‐ Enzymes that catalyze the first step leading to the oxidation…
- Tauopathy ‐ Neurodegenerative disorders involving deposition of abnormal…
- Vectorcardiographies ‐ Recording of the moment-to-moment electromotive forces of the…